Interleukin 1 (IL1) Market, Global Outlook and Forecast 2022-2028

Interleukin 1 (IL1) Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281547 | No. of Pages: 116 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Interleukin 1 (IL1) in global, including the following market information:
Global Interleukin 1 (IL1) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Interleukin 1 (IL1) Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Interleukin 1 (IL1) companies in 2021 (%)
The global Interleukin 1 (IL1) market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
APX-002 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Interleukin 1 (IL1) include Optimum Therapeutics LLC, Orphit SAS, Peptinov SAS, AbbVie Inc, Swedish Orphan Biovitrum AB, TWi Biotechnology Inc, XBiotech Inc, Cell Medica Ltd and Exicure Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interleukin 1 (IL1) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interleukin 1 (IL1) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Interleukin 1 (IL1) Market Segment Percentages, by Type, 2021 (%)
    APX-002
    Canakinumab
    Diacerein CR
    IR-1000
    Others
Global Interleukin 1 (IL1) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Interleukin 1 (IL1) Market Segment Percentages, by Application, 2021 (%)
    Esophageal Cancer
    Fallopian Tube Cancer
    Bladder Cancer
    Bechcer Disease
    Others
Global Interleukin 1 (IL1) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Interleukin 1 (IL1) Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Interleukin 1 (IL1) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Interleukin 1 (IL1) revenues share in global market, 2021 (%)
Key companies Interleukin 1 (IL1) sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Interleukin 1 (IL1) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Optimum Therapeutics LLC
    Orphit SAS
    Peptinov SAS
    AbbVie Inc
    Swedish Orphan Biovitrum AB
    TWi Biotechnology Inc
    XBiotech Inc
    Cell Medica Ltd
    Exicure Inc
    Immune Response BioPharma Inc
    Novartis AG
    Omnitura Therapeutics Inc
    Opsona Therapeutics Ltd
    Anacor Pharmaceuticals Inc
    Apexigen Inc
    R Pharm
    Regeneron Pharmaceuticals Inc
1 Introduction to Research & Analysis Reports
    1.1 Interleukin 1 (IL1) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Interleukin 1 (IL1) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Interleukin 1 (IL1) Overall Market Size
    2.1 Global Interleukin 1 (IL1) Market Size: 2021 VS 2028
    2.2 Global Interleukin 1 (IL1) Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Interleukin 1 (IL1) Sales: 2017-2028
3 Company Landscape
    3.1 Top Interleukin 1 (IL1) Players in Global Market
    3.2 Top Global Interleukin 1 (IL1) Companies Ranked by Revenue
    3.3 Global Interleukin 1 (IL1) Revenue by Companies
    3.4 Global Interleukin 1 (IL1) Sales by Companies
    3.5 Global Interleukin 1 (IL1) Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Interleukin 1 (IL1) Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Interleukin 1 (IL1) Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Interleukin 1 (IL1) Players in Global Market
        3.8.1 List of Global Tier 1 Interleukin 1 (IL1) Companies
        3.8.2 List of Global Tier 2 and Tier 3 Interleukin 1 (IL1) Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Interleukin 1 (IL1) Market Size Markets, 2021 & 2028
        4.1.2 APX-002
        4.1.3 Canakinumab
        4.1.4 Diacerein CR
        4.1.5 IR-1000
        4.1.6 Others
    4.2 By Type - Global Interleukin 1 (IL1) Revenue & Forecasts
        4.2.1 By Type - Global Interleukin 1 (IL1) Revenue, 2017-2022
        4.2.2 By Type - Global Interleukin 1 (IL1) Revenue, 2023-2028
        4.2.3 By Type - Global Interleukin 1 (IL1) Revenue Market Share, 2017-2028
    4.3 By Type - Global Interleukin 1 (IL1) Sales & Forecasts
        4.3.1 By Type - Global Interleukin 1 (IL1) Sales, 2017-2022
        4.3.2 By Type - Global Interleukin 1 (IL1) Sales, 2023-2028
        4.3.3 By Type - Global Interleukin 1 (IL1) Sales Market Share, 2017-2028
    4.4 By Type - Global Interleukin 1 (IL1) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Interleukin 1 (IL1) Market Size, 2021 & 2028
        5.1.2 Esophageal Cancer
        5.1.3 Fallopian Tube Cancer
        5.1.4 Bladder Cancer
        5.1.5 Bechcer Disease
        5.1.6 Others
    5.2 By Application - Global Interleukin 1 (IL1) Revenue & Forecasts
        5.2.1 By Application - Global Interleukin 1 (IL1) Revenue, 2017-2022
        5.2.2 By Application - Global Interleukin 1 (IL1) Revenue, 2023-2028
        5.2.3 By Application - Global Interleukin 1 (IL1) Revenue Market Share, 2017-2028
    5.3 By Application - Global Interleukin 1 (IL1) Sales & Forecasts
        5.3.1 By Application - Global Interleukin 1 (IL1) Sales, 2017-2022
        5.3.2 By Application - Global Interleukin 1 (IL1) Sales, 2023-2028
        5.3.3 By Application - Global Interleukin 1 (IL1) Sales Market Share, 2017-2028
    5.4 By Application - Global Interleukin 1 (IL1) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Interleukin 1 (IL1) Market Size, 2021 & 2028
    6.2 By Region - Global Interleukin 1 (IL1) Revenue & Forecasts
        6.2.1 By Region - Global Interleukin 1 (IL1) Revenue, 2017-2022
        6.2.2 By Region - Global Interleukin 1 (IL1) Revenue, 2023-2028
        6.2.3 By Region - Global Interleukin 1 (IL1) Revenue Market Share, 2017-2028
    6.3 By Region - Global Interleukin 1 (IL1) Sales & Forecasts
        6.3.1 By Region - Global Interleukin 1 (IL1) Sales, 2017-2022
        6.3.2 By Region - Global Interleukin 1 (IL1) Sales, 2023-2028
        6.3.3 By Region - Global Interleukin 1 (IL1) Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Interleukin 1 (IL1) Revenue, 2017-2028
        6.4.2 By Country - North America Interleukin 1 (IL1) Sales, 2017-2028
        6.4.3 US Interleukin 1 (IL1) Market Size, 2017-2028
        6.4.4 Canada Interleukin 1 (IL1) Market Size, 2017-2028
        6.4.5 Mexico Interleukin 1 (IL1) Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Interleukin 1 (IL1) Revenue, 2017-2028
        6.5.2 By Country - Europe Interleukin 1 (IL1) Sales, 2017-2028
        6.5.3 Germany Interleukin 1 (IL1) Market Size, 2017-2028
        6.5.4 France Interleukin 1 (IL1) Market Size, 2017-2028
        6.5.5 U.K. Interleukin 1 (IL1) Market Size, 2017-2028
        6.5.6 Italy Interleukin 1 (IL1) Market Size, 2017-2028
        6.5.7 Russia Interleukin 1 (IL1) Market Size, 2017-2028
        6.5.8 Nordic Countries Interleukin 1 (IL1) Market Size, 2017-2028
        6.5.9 Benelux Interleukin 1 (IL1) Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Interleukin 1 (IL1) Revenue, 2017-2028
        6.6.2 By Region - Asia Interleukin 1 (IL1) Sales, 2017-2028
        6.6.3 China Interleukin 1 (IL1) Market Size, 2017-2028
        6.6.4 Japan Interleukin 1 (IL1) Market Size, 2017-2028
        6.6.5 South Korea Interleukin 1 (IL1) Market Size, 2017-2028
        6.6.6 Southeast Asia Interleukin 1 (IL1) Market Size, 2017-2028
        6.6.7 India Interleukin 1 (IL1) Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Interleukin 1 (IL1) Revenue, 2017-2028
        6.7.2 By Country - South America Interleukin 1 (IL1) Sales, 2017-2028
        6.7.3 Brazil Interleukin 1 (IL1) Market Size, 2017-2028
        6.7.4 Argentina Interleukin 1 (IL1) Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Interleukin 1 (IL1) Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Interleukin 1 (IL1) Sales, 2017-2028
        6.8.3 Turkey Interleukin 1 (IL1) Market Size, 2017-2028
        6.8.4 Israel Interleukin 1 (IL1) Market Size, 2017-2028
        6.8.5 Saudi Arabia Interleukin 1 (IL1) Market Size, 2017-2028
        6.8.6 UAE Interleukin 1 (IL1) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Optimum Therapeutics LLC
        7.1.1 Optimum Therapeutics LLC Corporate Summary
        7.1.2 Optimum Therapeutics LLC Business Overview
        7.1.3 Optimum Therapeutics LLC Interleukin 1 (IL1) Major Product Offerings
        7.1.4 Optimum Therapeutics LLC Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.1.5 Optimum Therapeutics LLC Key News
    7.2 Orphit SAS
        7.2.1 Orphit SAS Corporate Summary
        7.2.2 Orphit SAS Business Overview
        7.2.3 Orphit SAS Interleukin 1 (IL1) Major Product Offerings
        7.2.4 Orphit SAS Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.2.5 Orphit SAS Key News
    7.3 Peptinov SAS
        7.3.1 Peptinov SAS Corporate Summary
        7.3.2 Peptinov SAS Business Overview
        7.3.3 Peptinov SAS Interleukin 1 (IL1) Major Product Offerings
        7.3.4 Peptinov SAS Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.3.5 Peptinov SAS Key News
    7.4 AbbVie Inc
        7.4.1 AbbVie Inc Corporate Summary
        7.4.2 AbbVie Inc Business Overview
        7.4.3 AbbVie Inc Interleukin 1 (IL1) Major Product Offerings
        7.4.4 AbbVie Inc Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.4.5 AbbVie Inc Key News
    7.5 Swedish Orphan Biovitrum AB
        7.5.1 Swedish Orphan Biovitrum AB Corporate Summary
        7.5.2 Swedish Orphan Biovitrum AB Business Overview
        7.5.3 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Major Product Offerings
        7.5.4 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.5.5 Swedish Orphan Biovitrum AB Key News
    7.6 TWi Biotechnology Inc
        7.6.1 TWi Biotechnology Inc Corporate Summary
        7.6.2 TWi Biotechnology Inc Business Overview
        7.6.3 TWi Biotechnology Inc Interleukin 1 (IL1) Major Product Offerings
        7.6.4 TWi Biotechnology Inc Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.6.5 TWi Biotechnology Inc Key News
    7.7 XBiotech Inc
        7.7.1 XBiotech Inc Corporate Summary
        7.7.2 XBiotech Inc Business Overview
        7.7.3 XBiotech Inc Interleukin 1 (IL1) Major Product Offerings
        7.7.4 XBiotech Inc Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.7.5 XBiotech Inc Key News
    7.8 Cell Medica Ltd
        7.8.1 Cell Medica Ltd Corporate Summary
        7.8.2 Cell Medica Ltd Business Overview
        7.8.3 Cell Medica Ltd Interleukin 1 (IL1) Major Product Offerings
        7.8.4 Cell Medica Ltd Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.8.5 Cell Medica Ltd Key News
    7.9 Exicure Inc
        7.9.1 Exicure Inc Corporate Summary
        7.9.2 Exicure Inc Business Overview
        7.9.3 Exicure Inc Interleukin 1 (IL1) Major Product Offerings
        7.9.4 Exicure Inc Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.9.5 Exicure Inc Key News
    7.10 Immune Response BioPharma Inc
        7.10.1 Immune Response BioPharma Inc Corporate Summary
        7.10.2 Immune Response BioPharma Inc Business Overview
        7.10.3 Immune Response BioPharma Inc Interleukin 1 (IL1) Major Product Offerings
        7.10.4 Immune Response BioPharma Inc Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.10.5 Immune Response BioPharma Inc Key News
    7.11 Novartis AG
        7.11.1 Novartis AG Corporate Summary
        7.11.2 Novartis AG Interleukin 1 (IL1) Business Overview
        7.11.3 Novartis AG Interleukin 1 (IL1) Major Product Offerings
        7.11.4 Novartis AG Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.11.5 Novartis AG Key News
    7.12 Omnitura Therapeutics Inc
        7.12.1 Omnitura Therapeutics Inc Corporate Summary
        7.12.2 Omnitura Therapeutics Inc Interleukin 1 (IL1) Business Overview
        7.12.3 Omnitura Therapeutics Inc Interleukin 1 (IL1) Major Product Offerings
        7.12.4 Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.12.5 Omnitura Therapeutics Inc Key News
    7.13 Opsona Therapeutics Ltd
        7.13.1 Opsona Therapeutics Ltd Corporate Summary
        7.13.2 Opsona Therapeutics Ltd Interleukin 1 (IL1) Business Overview
        7.13.3 Opsona Therapeutics Ltd Interleukin 1 (IL1) Major Product Offerings
        7.13.4 Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.13.5 Opsona Therapeutics Ltd Key News
    7.14 Anacor Pharmaceuticals Inc
        7.14.1 Anacor Pharmaceuticals Inc Corporate Summary
        7.14.2 Anacor Pharmaceuticals Inc Business Overview
        7.14.3 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Major Product Offerings
        7.14.4 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.14.5 Anacor Pharmaceuticals Inc Key News
    7.15 Apexigen Inc
        7.15.1 Apexigen Inc Corporate Summary
        7.15.2 Apexigen Inc Business Overview
        7.15.3 Apexigen Inc Interleukin 1 (IL1) Major Product Offerings
        7.15.4 Apexigen Inc Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.15.5 Apexigen Inc Key News
    7.16 R Pharm
        7.16.1 R Pharm Corporate Summary
        7.16.2 R Pharm Business Overview
        7.16.3 R Pharm Interleukin 1 (IL1) Major Product Offerings
        7.16.4 R Pharm Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.16.5 R Pharm Key News
    7.17 Regeneron Pharmaceuticals Inc
        7.17.1 Regeneron Pharmaceuticals Inc Corporate Summary
        7.17.2 Regeneron Pharmaceuticals Inc Business Overview
        7.17.3 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Major Product Offerings
        7.17.4 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales and Revenue in Global (2017-2022)
        7.17.5 Regeneron Pharmaceuticals Inc Key News
8 Global Interleukin 1 (IL1) Production Capacity, Analysis
    8.1 Global Interleukin 1 (IL1) Production Capacity, 2017-2028
    8.2 Interleukin 1 (IL1) Production Capacity of Key Manufacturers in Global Market
    8.3 Global Interleukin 1 (IL1) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Interleukin 1 (IL1) Supply Chain Analysis
    10.1 Interleukin 1 (IL1) Industry Value Chain
    10.2 Interleukin 1 (IL1) Upstream Market
    10.3 Interleukin 1 (IL1) Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Interleukin 1 (IL1) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com